雜志介紹

Oncology Letters雜志介紹

《Oncology Letters》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱腫瘤學(xué)快報(bào)，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.5，最新CiteScore 指數(shù)為5.7。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer

  Author: Zhu, Mengdi; Liu, Nianqiu; Lin, Jinna; Wang, Jingru; Lai, Hongna; Liu, Yujie

• Role of tumor-associated neutrophils in lung cancer (Review)

  Author: Zhou, Jinhua; Liu, Huan; Jiang, Shulong; Wang, Wei

• FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo

  Author: Zhao, Kun; Gao, Jie; Shi, Jihua; Shi, Chengcheng; Pang, Chun; Li, Jie; Guo, Wenzhi; Zhang, Shuijun

• Alcohol dehydrogenase 4 is a TP53-associated gene signature for the prediction of prognosis in hepatocellular carcinoma

  Author: Zhang, Yuan; Jiang, Hui-Hong; Wang, Zhen-Yu; Zhai, Bo; Lin, Mou-Bin

英文介紹

Oncology Letters雜志英文介紹

Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology, as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease.

The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology, chemotherapy, oncogenes, carcinogenesis, metastasis, epidemiology and viral oncology in the form of original research, reviews and case reports.